HEMOLYSIS OF NORMAL HUMAN ERYTHROCYTES BY AUTOLOGOUS SERUM COMPLEMENT

被引:12
作者
KITAMURA, H
NAGANO, A
KITANO, E
机构
[1] Department of Immunology, Center for Adult Diseases, Osaka
关键词
AUTOLOGOUS SERUM; COMPLEMENT ACTIVATION; ERYTHROCYTES; HEMOLYSIS; ZYMOSAN;
D O I
10.1159/000236413
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Unsensitized normal human erythrocytes (E) were shown to be lysed when incubated with autologous serum in the presence of zymosan (Zy). The hemolysis proceeded slowly with a relatively constant rate for at least 24 h at 37-degrees-C. It was shown that the hemolytic reaction is antibody independent and mediated by complement activation through the alternative pathway and that hemolysis is not due to the decay or inactivation of complement regulators present on the E membrane. The mechanism of the phenomenon was studied by use of several kinds of sera genetically deficient in C3, C5, C7 or C9. The reaction was found to be divided into two stages: in the first step, neither E, C5, C7 nor C9 but Zy, serum factors containing C3 and metal ions are necessary, and in the second step, neither C3 nor metal ions but E, C5, C7 and C9 are necessary. Thus, E seem to be lysed by reactive lysis induced by C5 convertase formed on Zy through alternative complement pathway activation.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 26 条
[1]  
ARROYAVE CM, 1974, J IMMUNOL, V113, P764
[2]   CHARACTERIZATION OF HUMAN S-PROTEIN, AN INHIBITOR OF THE MEMBRANE ATTACK COMPLEX OF COMPLEMENT - DEMONSTRATION OF A FREE REACTIVE THIOL-GROUP [J].
DAHLBACK, B ;
PODACK, ER .
BIOCHEMISTRY, 1985, 24 (09) :2368-2374
[3]   PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA TYPE-III - LACK OF AN ERYTHROCYTE-MEMBRANE PROTEIN RESTRICTING THE LYSIS BY C5B-9 [J].
HANSCH, GM ;
SCHONERMARK, S ;
ROELCKE, D .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :7-12
[4]   HOMOLOGOUS SPECIES RESTRICTION IN LYSIS OF ERYTHROCYTES BY TERMINAL COMPLEMENT PROTEINS [J].
HANSCH, GM ;
HAMMER, CH ;
VANGURI, P ;
SHIN, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :5118-5121
[5]  
HOULE JJ, 1984, J IMMUNOL, V133, P1444
[6]  
INAI S, 1979, J CLIN LAB IMMUNOL, V2, P85
[7]  
KITAMURA H, 1984, IMMUNOLOGY, V51, P239
[8]  
KITAMURA H, 1981, MOL IMMUNOL, V18, P985
[9]   ACTIVATED C56 FORMATION IN THE REACTION MIXTURE OF ISOLATED COMPLEMENT COMPONENTS THROUGH THE CLASSICAL COMPLEMENT PATHWAY [J].
KITAMURA, H ;
TSUBOI, M ;
NAGAKI, K .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1985, 78 (01) :101-107
[10]  
LINT TF, 1977, J IMMUNOL, V119, P883